NCT01153711View on ClinicalTrials.gov

Relative Bioavailability of of Olodaterol and Ketoconazole

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

August 31, 2010

Conditions
HealthyPulmonary Disease, Chronic Obstructive
Interventions
DRUG

BI 1744

10 mcg solution for oral inhalation

DRUG

BI 1744

10 mcg solution for oral inhalation

DRUG

Ketoconazole

400 mg tablet

DRUG

Ketoconazole

400 mg tablet

Trial Locations (1)

Unknown

1222.47.1 Boehringer Ingelheim Investigational Site, Ingelheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY